Skip to main content

Advances in Cancer Medicine: Our Momentum of Discovery

 

Featured Content |Content Library

Potential Targeted Therapy for Pediatric Brain Cancer Identified by Dana-Farber/Boston Children's Team News

Potential Targeted Therapy for Pediatric Brain Cancer Identified by Dana-Farber/Boston Children's Team

AI Learns Genomic “Language” to Advance Cancer Treatment News

AI Learns Genomic “Language” to Advance Cancer Treatment

Expanding Options for Patients with Ovarian Cancer News

Expanding Options for Patients with Ovarian Cancer

Novel Stem Cell Therapy Safely Repairs Irreversible Corneal Damage in Clinical Trial News

Novel Stem Cell Therapy Safely Repairs Irreversible Corneal Damage in Clinical Trial

Kimberly Stegmaier named as Pediatric Oncology Chair at Dana-Farber News

Kimberly Stegmaier named as Pediatric Oncology Chair at Dana-Farber

Dana-Farber Researchers Present Findings at 2025 ASCO Genitourinary Cancers Symposium News

Dana-Farber Researchers Present Findings at 2025 ASCO Genitourinary Cancers Symposium

Education/CME

Receive Dana-Farber's
e-newsletter, Momentum,
to learn of advances in cancer research and care, current clinical trials, and upcoming CME programs.